The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. 1990

W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
Duke University Bone Marrow Transplant Program, Department of Medicine, Pathology.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer

Related Publications

W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
January 1991, Bone marrow transplantation,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
January 1991, American journal of clinical oncology,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
January 1993, Cancer investigation,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
August 1988, Blood,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
June 1991, The New England journal of medicine,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
June 1989, Lancet (London, England),
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
August 1988, Behring Institute Mitteilungen,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
July 1990, Blood,
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
June 1996, European journal of cancer (Oxford, England : 1990),
W P Peters, and J Kurtzberg, and S Atwater, and M Borowitz, and M Rao, and M Currie, and C Gilbert, and E J Shpall, and R B Jones, and M Ross
August 1988, Behring Institute Mitteilungen,
Copied contents to your clipboard!